Swiss Life Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$168M Sell
1,305,364
-76,487
-6% -$8.95M 0.69% 25
2026
Q1
$166M Buy
1,381,851
+163,951
+13% +$18.9M 0.81% 18
2025
Q4
$128M Buy
1,217,900
+60,267
+5% +$5.66M 0.65% 24
2025
Q3
$97.2M Buy
1,157,633
+42,471
+4% +$3.5M 0.51% 35
2025
Q2
$88.3M Buy
1,115,162
+304,817
+38% +$24.2M 0.52% 39
2025
Q1
$72.7M Buy
810,345
+168,388
+26% +$15.7M 0.53% 38
2024
Q4
$63.8M Buy
641,957
+221,767
+53% +$22.9M 0.47% 42
2024
Q3
$47.7M Sell
420,190
-16,725
-4% -$1.99M 0.54% 33
2024
Q2
$54.1M Buy
436,915
+50,231
+13% +$6.47M 0.64% 26
2024
Q1
$51M Sell
386,684
-121,368
-24% -$15M 0.71% 24
2023
Q4
$55.4M Buy
508,052
+66,242
+15% +$6.88M 0.67% 22
2023
Q3
$45.5M Sell
441,810
-105,300
-19% -$11.3M 0.7% 23
2023
Q2
$63.1M Sell
547,110
-49,098
-8% -$5.57M 0.93% 10
2023
Q1
$63.4M Buy
596,208
+2,719
+0.5% +$294K 0.95% 10
2022
Q4
$66M Sell
593,489
-28,785
-5% -$2.94M 1.1% 9
2022
Q3
$53.6M Buy
622,274
+3,580
+0.6% +$320K 0.93% 12
2022
Q2
$56.5M Buy
618,694
+38,817
+7% +$3.44M 0.91% 12
2022
Q1
$47.5M Buy
579,877
+38,584
+7% +$3.04M 0.67% 26
2021
Q4
$41.5M Sell
541,293
-89,486
-14% -$7.13M 0.54% 32
2021
Q3
$47.4M Buy
630,779
+41,148
+7% +$3.13M 0.66% 23
2021
Q2
$36.4M Sell
589,631
-15,268
-3% -$1.14M 0.37% 41
2021
Q1
$44.5M Buy
604,899
+1,499
+0.2% +$111K 0.64% 22
2020
Q4
$47.1M Sell
603,400
-616,050
-51% -$47.1M 0.69% 23
2020
Q3
$96.5M Sell
1,219,450
-57,210
-4% -$4.48M 1.43% 7
2020
Q2
$94.2M Buy
1,276,660
+68,379
+6% +$5.15M 1.52% 6
2020
Q1
$88.7M Buy
1,208,281
+156,800
+15% +$12.3M 1.69% 6
2019
Q4
$91.3M Sell
1,051,481
-690,172
-40% -$56.7M 1.73% 5
2019
Q3
$140M Sell
1,741,653
-394,751
-18% -$31.6M 1.82% 7
2019
Q2
$171M Buy
2,136,404
+97,846
+5% +$7.49M 2.06% 6
2019
Q1
$162M Buy
2,038,558
+945,645
+87% +$70.7M 2.05% 6
2018
Q4
$79.7M Sell
1,092,913
-144,059
-12% -$10.2M 1.62% 12
2018
Q3
$83.7M Buy
1,236,972
+716,844
+138% +$45.7M 1.12% 15
2018
Q2
$30.1M Buy
520,128
+12,070
+2% +$681K 0.45% 59
2018
Q1
$26.4M Buy
508,058
+18,408
+4% +$994K 0.46% 58
2017
Q4
$26.3M Buy
489,650
+102,418
+26% +$5.68M 0.59% 56
2017
Q3
$23.6M Buy
387,232
+52,203
+16% +$3.16M 0.63% 50
2017
Q2
$20.5M Sell
335,029
-49,313
-13% -$3M 0.53% 56
2017
Q1
$23.3M Sell
384,342
-123,722
-24% -$7.51M 0.63% 38
2016
Q4
$28.5M Sell
508,064
-17,521
-3% -$1.03M 0.96% 17
2016
Q3
$31.3M Buy
525,585
+39,635
+8% +$2.32M 1.07% 9
2016
Q2
$26.7M Sell
485,950
-18,403
-4% -$979K 1.1% 10
2016
Q1
$25.5M Sell
504,353
-12,393
-2% -$607K 1.07% 10
2015
Q4
$26M Sell
516,746
-22,044
-4% -$1.11M 1.16% 9
2015
Q3
$25.4M Buy
538,790
+84,647
+19% +$4.5M 1.24% 9
2015
Q2
$24.7M Buy
454,143
+12,841
+3% +$720K 0.87% 10
2015
Q1
$24.2M Buy
+441,302
New +$25M 0.98% 10

Other funds holding MRK

Swiss Life Asset Management's MRK Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Merck (MRK) stake by 5.5% in Q2 2026, selling an estimated $8.95M and leaving 1,305,364 shares worth $168M. The position accounts for 0.69% of the portfolio, ranked #25.

Swiss Life Asset Management first reported a position in MRK in Q1 2015 and has held it in 46 quarters since. The position peaked at $171M in Q2 2019. 3,080 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Swiss Life Asset Management held 1,305,364 shares of Merck worth $168M as of Q2 2026.
  • Swiss Life Asset Management sold 76,487 Merck shares in Q2 2026, an estimated $8.95M.
  • Merck made up 0.69% of Swiss Life Asset Management's portfolio in Q2 2026, its #25 holding.
  • Swiss Life Asset Management first reported a position in Merck in Q1 2015 and has held it in 46 quarters since.
  • Swiss Life Asset Management's Merck position peaked at $171M in Q2 2019.
  • 3,080 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.